BrightView Health
-
Services:
- Vaping permitted in designated area
- Drug Enforcement Agency (DEA)
- The Joint Commission
- SAMHSA certification for opioid treatment program (OTP)
- Assistance with obtaining social services
- Housing services
- Mentoring/peer support
- Case management service
- Transportation assistance
- Suicide prevention services
- Domestic violence services, including family or partner
- Social skills development
- Integrated primary care services
- Naloxone and overdose education
- Outcome follow-up after discharge
- Aftercare/continuing care
- Discharge Planning
- Adults
- Young Adults
- Private for-profit organization
- Intensive outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Outpatient detoxification
- Outpatient day treatment or partial hospitalization
- Regular outpatient treatment
- Group counseling
- Substance use disorder education
- Individual counseling
- Lofexidine or Clonidine detoxification
- Relapse prevention with naltrexone
- Buprenorphine maintenance
- Accepts clients using MAT but prescribed elsewhere
- Prescribes buprenorphine
- Buprenorphine detoxification
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes naltrexone
- Screening for tobacco use
- Screening for mental disorders
- Complete medical history/physical exam
- Comprehensive substance use assessment
- Outreach to persons in the community
- Screening for substance use
- Private health insurance
- Federal military insurance (e.g., TRICARE)
- Cash or self-payment
- Medicare
- State-financed health insurance plan other than Medicaid
- Medicaid
- Drug or alcohol urine screening
- Telemedicine/telehealth therapy
- Motivational interviewing
- Contingency management/motivational incentives
- Trauma-related counseling
- Community reinforcement plus vouchers
- Relapse prevention
- Substance use disorder counseling
- Cognitive behavioral therapy
- Sliding fee scale (fee is based on income and other factors)
- Alcohol Detoxification
- Methamphetamines detoxification
- Benzodiazepines Detoxification
- Opioids detoxification
- Cocaine Detoxification
- Medication routinely used during detoxification
- Substance use treatment
- Detoxification
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- In-network prescribing entity
- Non-nicotine smoking/tobacco cessation
- Disulfiram
- Buprenorphine (extended-release, injectable)
- Buprenorphine sub-dermal implant
- Clonidine
- Acamprosate (Campral®)
- Naltrexone (oral)
- Nicotine replacement
- Naltrexone (extended-release, injectable)
- Buprenorphine without naloxone
- Buprenorphine with naloxone
- In-network prescribing entity
- Sign language services for the deaf and hard of hearing
- This facility administers/prescribes medication for alcohol use disorder
- Female
- Male
- Smoking permitted in designated area
Facility Vaping Policy
License/Certification/Accreditation
Recovery Support Services
Ancillary Services
Transitional Services
Age Groups Accepted
Facility Operation (e.g., Private, Public)
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Education and Counseling Services
Type of Opioid Treatment
Assessment/Pre-treatment
Payment/Insurance/Funding Accepted
Testing
Treatment Approaches
Payment Assistance Available
Detoxification (medical withdrawal) Services
Type of Care
Opioid Medications used in Treatment
External Source of Medications Used for Alcohol Use Disorder Treatment
Pharmacotherapies
External Opioid Medications Source
Language Services
Type of Alcohol Use Disorder Treatment
Gender Accepted
Facility Smoking Policy